See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2023_NeuBase_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001173281, NeuBase Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 24,648,665 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 2,156,851 |
3 | remainder_Assets | 5,887,913 |
4 | LiabilitiesCurrent | 4,166,385 |
5 | LiabilitiesNoncurrent | 5,335,164 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 11,869,747 |
9 | ResearchAndDevelopmentExpense | 21,448,592 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -458,111 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 32,693,429 |
1 | Liabilities | 9,501,549 |
2 | Expenses | 33,318,339 |
3 | Revenues | 0 |
4 | StockholdersEquity | 23,191,880 |
5 | NetIncome | -33,776,450 |
6 | ComprehensiveNetIncome | -33,776,450 |
7 | BaseVar | 37,985,714 |
8 | EconomicCapitalRatio | 0.290 |